2025 · 4th Quarter (Oct 1 - Dec 31)

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Filed by BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.).

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: Not reported
Expenses: $290,000.00
Registrant: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client: BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Filing UUID: 048d7e4d-9f2a-4627-b223-c37a0af6c6c0
Termination date: Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 - Continuing Appropriations and Extensions Act of 2026

Literal federal measure citations: H.R. 5304, S. 2587, H.R. 5371

HCR · Health Issues

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians H.R. 5467 - Patient Access to Autoimmune Treatments Act Issues pertaining to NIH research Issues pertaining to prior authorization Issues pertaining to cell and gene therapies Issues pertaining to C-peptide Issues pertaining to insulin affordability

Literal federal measure citations: S. 2211, H.R. 5461, H.R. 5488, H.R. 5467

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.